NEW YORK (GenomeWeb News) – Toronto-based GeneNews said that it has issued five-year, 15 percent redeemable convertible secured debentures in the aggregate principal amount of C$1.1 million (US$900,000).
The issuance represents the initial closing of a private placement offering of debentures, under which the firm’s board of directors has authorized the sale of up to C$3.45 million in debentures. The 15 percent annual interest will be paid upon the earlier of maturity, conversion, or redemption of the debentures.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.